H/M threshold
Showing 1 - 25 of >10,000
Pain, Postoperative, Anesthesia, Catastrophizing Trial in Montréal-Est (device, diagnostic test, biological)
Recruiting
- Pain, Postoperative
- +3 more
- Standardized tetanic stimulation
- +3 more
-
Montréal-Est, Quebec, CanadaHopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montre
Oct 1, 2021
Age, Frequency and Test Threshold
Enrolling by invitation
- Breast Cancer
- Increase in upper age of eligibility for breast cancer screening from 64 to 70
- +2 more
-
Coventry, Warwickshire, United KingdomUniversity of Warwick
Jun 1, 2022
Alzheimer, Subjective Cognitive Decline Trial in Toronto (Active Brainsway H7-Coil Deep TMS System, Sham Brainsway H7-Coil Deep
Recruiting
- Alzheimer Disease
- Subjective Cognitive Decline
- Active Brainsway H7-Coil Deep TMS System
- +2 more
-
Toronto, Ontario, CanadaRotman Research Institute at Baycrest
Oct 20, 2023
Mantle Cell Lymphoma (MCL) Trial in Australia, Canada, United States (Acalabrutinib, Venetoclax, Rituximab)
Not yet recruiting
- Mantle Cell Lymphoma (MCL)
- Acalabrutinib
- +2 more
-
Duarte, California
- +11 more
Jul 17, 2023
Type 1 Diabetes Trial in Montreal (other, device, drug)
Recruiting
- Type 1 Diabetes
- Test to induce a decline in plasma glucose
- +3 more
-
Montreal, Quebec, CanadaMontreal Clinical Research Institute
Oct 7, 2022
H3 K27M, Glioma Trial in Santa Monica (ONC201, ONC201 + Placebo, Placebo)
Recruiting
- H3 K27M
- Glioma
- ONC201
- +2 more
-
Santa Monica, CaliforniaProvidence Saint John's Cancer Institute
Nov 28, 2022
Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)
Not yet recruiting
- Bipolar Disorder
- Cannabidiol
- Placebo
-
Calgary, Alberta, Canada
- +7 more
May 18, 2023
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Cladribine
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 18, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Terminated
- Locally Advanced Malignant Solid Neoplasm
- +2 more
- Pembrolizumab
- Pevonedistat
-
Houston, TexasM D Anderson Cancer Center
Dec 22, 2022
Diffuse Midline Glioma, H3 K27M-Mutant Trial in San Francisco (Cyclophosphamide, Fludarabine, Autologous Anti-H3.3K27M
Not yet recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- Cyclophosphamide
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 15, 2022
Risk Factors for Shoulder Joint Motion Restriction
Not yet recruiting
- Breast Cancer Survivors
- measurement of tissue stiffness (N/m)
- +7 more
-
Istanbul, Turkeyİstanbul Medeniyet University
May 25, 2022
Hyperalgesia, Mechanical Trial in Iksan (Remimazolam, Desflurane)
Recruiting
- Hyperalgesia, Mechanical
- Remimazolam, Desflurane
-
Iksan, Jeollabukdo, Korea, Republic of
- +1 more
May 9, 2023
Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)
Not yet recruiting
- Healthy
- H107e
- +10 more
-
Pretoria, Gauteng, South AfricaAurum Institute
Sep 24, 2023
Diffuse Intrinsic Pontine Glioma Trial in Beijing (Histone H3.3-K27M Neoantigen Vaccine Therapy)
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Histone H3.3-K27M Neoantigen Vaccine Therapy
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Jul 18, 2022
Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)
Recruiting
- Prostate Cancer Metastatic
- Ablative Radiation Therapy
- Standard of care
-
Victoria, British Columbia, Canada
- +14 more
Nov 14, 2022
Prostate Cancer Trial in Canada (PSMA PET/CT guided intensification of therapy, Control Arm)
Recruiting
- Prostate Cancer
- PSMA PET/CT guided intensification of therapy
- Control Arm
-
Kelowna, British Columbia, Canada
- +13 more
Dec 14, 2022
Rectal Cancer Trial in Beijing, Shanghai, Chengdu (Dissection of the No.253 lymph node, Omitting the dissection of the No.253
Not yet recruiting
- Rectal Cancer
- Dissection of the No.253 lymph node
- Omitting the dissection of the No.253 lymph node
-
Beijing, Beijing, China
- +6 more
Nov 27, 2023
CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)
Not yet recruiting
- Central Nervous System Neoplasms
- +6 more
- B7-H3-CAR T cells
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 18, 2023
Chronic Pain, Knee Pain Chronic, Post Operative Pain Trial in Toronto (Vitamin C, Placebo)
Not yet recruiting
- Chronic Pain
- +2 more
- Vitamin C
- Placebo
-
Toronto, Ontario, Canada
- +2 more
Nov 7, 2023
Tumors, Colorectal Cancer Trial in Grand Rapids, Nashville, Kirkland (MK-8353, Pembrolizumab)
Completed
- Neoplasms
- Colorectal Cancer
- MK-8353
- Pembrolizumab
-
Grand Rapids, Michigan
- +2 more
Dec 21, 2022
Influenza Trial in Toronto, Mirabel, Pointe-Claire (H1 influenza antigen)
Completed
- Influenza
- H1 influenza antigen
-
Toronto, Ontario, Canada
- +2 more
Nov 3, 2023
Consciousness and Nociception During Anesthesia
Not yet recruiting
- Nociceptive Pain
- Anesthesia
- EEG-hd (high density electroencephalogram)
-
Montréal, Quebec, CanadaHopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montré
May 18, 2023
Prostate Cancer Trial in Vancouver, Toronto, Montréal (Survivorship Care Plan)
Active, not recruiting
- Prostate Cancer
- Survivorship Care Plan
-
Vancouver, British Columbia, Canada
- +2 more
Nov 14, 2022
Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)
Terminated
- Renal Cell Carcinoma
- Nivolumab
- Ipilimumab
-
Saint Louis, Missouri
- +11 more
Dec 15, 2022
Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)
Active, not recruiting
- Oropharyngeal Cancer
- Radiation
- Cisplatin
-
Prince George, British Columbia, Canada
- +13 more
Dec 12, 2022